Dompe Farmaceutici SPA
http://www.dompe.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Dompe Farmaceutici SPA
China Approves Record New Cancer, Orphan Drugs In 2020 But Access Challenges Remain
Throughout 2020, China’s drive to introduce more and newer drugs to the market did not slow but was rather accelerated by the COVID-19 pandemic. But can people afford them?
Cancer, Rare Disease Drugs Among New China Approvals
Rare disease and cancer treatments are front and center in the latest batch of China new drug approvals, while biosimilars are expected to move into the spotlight.
Coronavirus Notebook: Drugs Old & New, Equitable Access To Vaccines, And Vial Supplies
In this edition of the Coronavirus Notebook, an EU consortium uses a supercomputing platform to identify the generic drug raloxifene as a potential COVID-19 treatment, and the World Health Organization proposes a set of principles for distributing a coronavirus vaccine at global level.
Italy’s Dompé Taking Legal Action Over COVID-19 Fake News
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.
Company Information
- Industry
- Pharmaceuticals